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The measurement of lung water
Neale R. Lange and Daniel P. Schuster
Introduction: In this review, we compare the spectrum of currently available
methods for quantifying pulmonary edema in patients.
Review: Imaging and indicator dilution techniques comprise the most common
strategies for measuring lung water at the bedside. The most accurate (within
10% of the gravimetric gold standard) and most reproducible (<5% between-
test variation) are also, unfortunately, the most expensive and most difficult to
implement for purposes of large-scale clinical trials or for routine clinical practice.
Conclusion: The standard chest radiograph remains the best screening test for
the detection of pulmonary edema. Indicator-dilution techniques are probably the
best available method at present for quantitation in patient groups.
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Introduction
Although about 80% of the lung is made up of water, gas-
exchanging air spaces are protected by various barriers
and drains. In multiple disease states, through injury or
pressure (or both), these protective mechanisms fail,
resulting in the abnormal accumulation of extravascular
lung water (EVLW). The principle paradigm describing
fluid flux in the lung is the ‘Starling equation’, which can
be modified to account for the total surface area over
which filtration might occur. ‘Lymph flow’ is a term sum-
marizing those mechanisms responsible for returning
extravasated fluid to the vascular compartment:
EVLW=(Lp×S)[(P c–Pi)–s(Pc–Pi)]–lymph flow [1]
where EVLW=extravascular lung water (ml), Lp=the
hydraulic conductivity for water (cm/min/mmHg), S=
surface area (cm2), Pc and Pi=the hydrostatic pressure
within the capillary and interstitial spaces respectively
(mmHg), s=the reflection coefficient for protein (no
units), and Pc and Pi=the oncotic pressure within the cap-
illary and interstitial spaces (mmHg).
This equation describes the formation of interstitial
edema accommodated by the interstitium. Subsequent
movement of fluid into the air spaces develops by a more
rapid process, termed alveolar flooding [2,3]. Normally
EVLW is <500ml [4–7]. With alveolar flooding, lung
water content is usually >75–100% above normal [8]. It is
at this point that physiologic impairment usually occurs.
Thus, any method that would be clinically useful must be
able to detect changes in EVLW below the threshold of
alveolar edema.
Although outcome has never been shown to be linked
directly to the amount, or even continued presence, of
pulmonary edema per se, the possibility that sufficiently
sensitive and accurate techniques could be used to detect
pulmonary edema even before it becomes apparent clini-
cally, or could be used to provide information about the
natural history of pulmonary edema or its response to
therapeutic intervention, is so inherently attractive that
the effort to develop and validate such techniques still
continues.
The ideal test should be accurate, sensitive, reproducible,
non-invasive, practical and inexpensive [9]. There is no
single ideal clinical test. Experimentally, EVLW can be
evaluated and measured by histologic or gravimetric
methods [10]. This comparative review focuses attention
specifically on those methods, which can be clinically
applied.
EVLW = extravascular lung water; PET = positron emission tomography; CT = computed tomography; NMR = nuclear magnetic resonance;
ARDS = acute respiratory distress syndrome; EIT = electrical impedance tomography; ETV, extravascular thermal volume; PTV = pulmonary
thermal volume; PEEP = positive end-expiratory pressure
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General comments
Common to all imaging methods is spatial information and
physical volume. Each picture (pixel) or volume (voxel)
element in a cross-sectional image of the lungs represents
a specific physical volume. Thus, the units for a variable
within that element are those of concentration (e.g. ml
EVLW/ml lung). Since the lung is an air containing struc-
ture, the amount of lung parenchyma within each voxel
can change, depending on the underlying state of lung
inflation (lung volume). To quantify changes in images of
EVLW in absolute terms, the signal over the entire organ
must be integrated.
Most imaging methods (except positron emission tomog-
raphy; PET) for evaluating pulmonary edema (Table 1) do
not estimate EVLW per se, but instead produce estimates
of total water content or concentration (i.e. vascular +
extravascular water). The data from such methods can be
misinterpreted if the blood volume of the lungs is not con-
stant. Although spatially specific to varying degrees, no
modality can resolve composition of edema on density
alone since the edema, blood and inflammatory white cells
are virtually identical, leading in general to an overestima-
tion of EVLW per se. Certainly no modality can differenti-
ate between intra- and extracellular water.
Chest radiography
A chest roentgenogram is commonly used to detect
whether or not pulmonary edema is present, to describe its
overall distribution within the lung, and to evaluate associ-
ated findings to infer a probable etiology. It can also be
used, at least semi-quantitatively, to estimate the amount of
pulmonary edema that is present as well. Several features of
the chest radiograph make such an interpretation possible:
(1) certain characteristic ‘signs’ are associated with only
modest increases in EVLW (perhaps as little as 30% above
normal values) [11] such as pulmonary ‘congestion’, vascu-
lar ‘redistribution’, peribronchial cuffing, perihilar ‘haze’,
Kerley’s lines, and an ‘interstitial’ pattern to the radi-
ographic densities; (2) as EVLW increases, the radiographic
densities occupy a greater fraction of the total lung airspace
(often, mild-to-moderate amounts of edema are present in
gravity-dependent lung regions only, while more severe
increases in EVLW involve both dependent and non-
dependent lung) [12]; and (3) as edema worsens and water
displaces air in any given lung region, the ‘density’ of the
‘infiltrate’ also worsens, becoming more and more ‘white’.
Although relatively quantitative and potentially informa-
tive as to etiology, accuracy (the amount of EVLW present)
is significantly limited by acquisition techniques and clini-
cal issues that override standardization procedures [13,14]
(especially in the critically ill). Under clinically relevant
conditions, the correlation of EVLW by chest radiography
to other established techniques has been weak [15].
Computed tomography
The principle advantages of using X-ray computed tomog-
raphy (CT) over conventional radiography are that the
density of the infiltrates can be determined quantitatively,
the spatial distribution of edema in transverse sections can
be defined, and, of course, associated (and at times clini-
cally relevant) findings can be identified. Lung density
can be quantified with X-ray CT because the arbitrary
Hounsfield units used for CT display can be calibrated
against objects or substances of known density. Experi-
mentally, CT-derived estimates of lung density increase
by 69% when gravimetric measurements of lung weight
increase by about 250% [16] (this difference in the per-
centage increase does not really indicate anything about
accuracy since the units of measurement are not the
same). CT densitometry is able to detect rather modest
(~50%) increases in EVLW in experimental animals [17].
Obviously, it is not portable and involves exposure to ion-
izing radiation.
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Table 1
Clinically appropriate methods to quantify pulmonary edema
Measures Quantitation Accuracy* Reproducibility (COV) Sensitivity†
CXR LD Poor Unknown Unknown Moderate
CT LD Excellent Unknown‡ Unknown‡ High
NMR TLW Fair Underestimates by –40%§ 5–10% Poor¶
PET EVLW Excellent Underestimates by 10–15% < 5% High
ID EVLW Good–excellent Overestimates by 10–20%# 4–8% Moderate
*None of the methods can distinguish whether an increase in
extravascular lung water (EVLW) represents non-cellular pulmonary
edema or cellular water from an inflammatory infiltrate. †Sensitivity to
change. ‡Presumably excellent, but formal studies never performed.
§The underestimates are primarily in normal or mildly edematous lungs.
¶The poor sensitivity is primarily in normal or mildly edematous lungs.
#The overestimation is primarily in normal or mildly edematous lungs.
TLW, total lung water (of a region on an image); LD, lung density;
COV, coefficient of variation; CXR, chest X-ray; CT, computed
tomography; NMR, nuclear magnetic resonance; PET, positron
emission tomography; ID, indicator dilution methods.
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Another emerging approach to estimating lung water
content is based on the ability to align hydrogen nuclei
(protons) of water in the direction of an externally applied
magnetic field [18]. When a subject lays within a magnetic
field and is then irradiated with electromagnetic radiation
in the form of a correctly applied radiofrequency pulse,
‘resonance’ (i.e. ‘nuclear magnetic resonance’) develops
from the absorption and subsequent release of energy as
the pulse is applied and discontinued. This energy can be
detected with appropriately placed amplifiers, producing a
signal of varying strength, depending on the strength of
the magnetic field and the frequency of the radiofre-
quency pulse. The spin-echo sequence is the only one to
date that has been employed to measure lung water.
Signal intensity, detected after a spin-echo pulse sequence,
varies as a function of the time it is sampled once the 90°
radiofrequency pulse is stopped (the ‘relaxation’ time).
Generally, proton density images have been obtained with
pulse sequences that minimize the effects of both T1 and
T2 weighting. Including a negative vascular contrast mater-
ial (coated magnetite) into the imaging protocol allows the
measurement EVLW [19] (studies on rats only).
Repeated measures of lung water by NMR vary by about
5–10% [20]. Numerous studies have reported a good corre-
lation between NMR-determined estimates of lung water
and estimates from the gold-standard gravimetric method
[21–26]. A problem intrinsic to NMR imaging is that
normal or mildly edematous lung produces relatively little
signal using conventional spin-echo sequences on 1.5
Tesla imagers typically used for clinical purposes [18,25].
As a result, NMR methods can underestimate true lung
water in absolute terms by as much as 20–40% [20,27,28]
(despite the good correlation with gravimetric methods).
This loss of signal is due to artifacts caused by the distinct
and separate magnetic susceptibilities of both air and soft-
tissue in the normally inflated lung. These artifacts, and
therefore the loss of signal, are magnified by the strength
of the external magnetic field. Recently, an imager that
has only one-tenth the strength of most clinical scanners
has been used along with a multi-echo pulse sequence
(i.e. a 90° radiofrequency pulse followed by multiple 180°
pulses) to minimize the effect of the air–soft-tissue arti-
fact, resulting in an excellent correlation, even in absolute
terms, between NMR and gravimetrically determined
lung water [29]. This same NMR imaging sequence has
also been successfully applied to normal volunteers [29].
T1 and T2 vary according to the type of tissue being exam-
ined, raising the theoretical possibility that NMR imaging
could be used to identify differences in the composition of
pulmonary edema generated by high intravascular pres-
sures (low protein) as opposed to increased vascular per-
meability (high protein), potentially allowing the edema of
heart failure to be distinguished non-invasively from the
edema of acute respiratory distress syndrome (ARDS).
These distinctions have been made (in rats) with the use
of a 40000 Dalton contrast material [30].
Cutillo et al. [31] have actually reported a method of NMR
image analysis that takes advantage of the same signal loss
artifact (the one caused by the air–soft-tissue interface)
that confounds the measurement of proton density in
absolute terms (and therefore of lung water) in the nor-
mally inflated lung. Since the air–soft-tissue interface is
minimized as alveolar edema develops, the expected loss
of signal is reduced. This difference in signal loss can be
measured, leading to inferences about the location of the
developing edema (alveolar edema causing less loss of
signal than interstitial edema). To date, however, the
method has only been applied to studies in rats [31].
In summary, the technique of NMR imaging continues to
be developed as a quantitative tool to measure and
monitor the development of pulmonary edema. An impor-
tant advantage of using NMR to evaluate lung water is
that the measurements can be obtained without any need
for ionizing radiation. It is expensive, however, and even
once the technical hurdles including respiratory and
cardiac motion are overcome, considerable difficulty will
undoubtedly be encountered when trying to implement
such methods in the critically ill patient.
Positron emission tomography
Lung water can be measured by external residue detec-
tion techniques, after separately administering radioac-
tively labeled tracers that distribute within the total and
intravascular water spaces of the lung. Emissions are then
detected with a device such as a gamma camera or a PET
scanner. PET is widely held to be the gold standard for
measuring EVLW (amongst the nuclear medicine tech-
niques) because a tomographic image can then be created
and normalized for the attenuation of the structure being
imaged using a transmission (sometimes referred to as an
attenuation) scan [32].
Lung water content can be measured either directly, or
estimated from tissue density measurements [32,33]. With
this approach, the water fraction of lung tissue must be
assumed (0.82–0.84ml/g). A small (~2%) correction for dif-
ferences in tissue versus blood density can also be incor-
porated [34].
When lung water (instead of lung density) is measured
directly, a sample of sterile water is labeled with a positron-
emitting isotope, such as oxygen-15 (H2
15O) (half-life =
2.06min), and then administered intravenously. The O-15
labeled water is allowed to equilibrate within tissue water
over a 3–4min period (this makes inaccuracies from areas of
hypoperfusion less significant), and the isotope’s activity
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ity data in the PET image are scaled to simultaneously
obtained activity in the blood, the image can be displayed as
a quantitative regional map of lung water distribution [35].
An analogous approach is used to measure the blood
volume concentration in the images. In this case, O-15 (or,
alternatively, C-11) labeled carbon monoxide is used
instead of O-15 water. If O-15 carbon monoxide is used,
trace amounts of C15O are inhaled as a gas, binding imme-
diately to blood hemoglobin. After a few minutes, to allow
equilibration within the body’s blood volume, another
PET scan is obtained. When again normalized to activity
measurements in blood and corrected for attenuation, the
image is a regional display of blood volume. An alternative
to using peripheral blood samples is to measure the activ-
ity within the blood pool of a cardiac chamber. In this
case, a further correction is necessary for the so-called
‘partial volume averaging effect’ (~5–10% in humans),
which occurs as a result of the limited spatial resolution of
PET relative to the size of the ventricular chamber [34].
With the assumption that 84% of blood is water (a reason-
able assumption at normal hematocrits), the blood water
content in a lung region can be subtracted from the total
lung water concentration, yielding a derived image of
extravascular water concentration [36]. The total time
required to measure EVLW with PET is about 45min,
but repeat measurements can begin in as little as
10–15min from the previous one.
Two previous studies showed that EVLW measurements
by PET correlated well with EVLW measurements
obtained by gravimetrics (r=0.86–0.93), even though cor-
rections for potential differences in peripheral versus capil-
lary hematocrit, or for differences in tissue versus blood
density were not included [36,37]. Perhaps because such
corrections were not incorporated, PET estimates of
EVLW systematically underestimated the gravimetric esti-
mates by about 10–15%. PET measurements, however, are
highly reproducible (coefficient of variation for repeat mea-
surements <5%) and linear (r=0.99 for changes in lung
water over a 20-fold concentration range) [37]. The method
also shows exquisite sensitivity: as little as 1ml additional
extravascular water can be detected with PET [37].
Despite these impressive performance characteristics, PET
imaging is expensive (like NMR) and not widely distributed
among medical centers (unlike NMR). Positron-emitting
isotopes also produce ionizing radiation (although the
amounts used in any one study are quite low). As with X-ray
CT or NMR imaging, the patient must be taken to the PET
facility for study, an obvious problem in critically ill patients.
Electrical impedance tomography (EIT)
Air and liquid offer different resistances to the flow of
electricity through the body. Measuring thoracic bioelec-
trical impedance in response to a low amplitude alternat-
ing electric current passed through the body yields a value
for resistivity which can be correlated to gravimetric
EVLW after correction for weight [38–40]. Recent refine-
ment using ‘dynamic’ cross-sectional reconstruction of this
information ‘gated’ to the cardiac cycle (a source of elec-
tricity) may make this portable test more sensitive and
specific [41] and, eventually, clinically attractive.
Indicator dilution methods
EVLW measurements can be obtained by indicator dilu-
tion methods using either the so-called ‘mean transit time’
or ‘slope–volume’ approaches to analyze the tempera-
ture–time or concentration–time data [42–45].
With the indicator dilution method, a freely diffusible
(heat/cold) and a non-diffusible (indocyanine green dye
which binds to albumin) indicator each have the same
flow but through different volumes of distribution. The
difference in the mean transit times of the two indicators
is therefore extravascular thermal volume (ETV). In the
slope–volume method, a slope for the linear decay of the
thermodilution curve is determined by mixing within the
largest volume through which the thermal indicator passes
(lungs). When multiplied by the cardiac output, pul-
monary thermal volume (PTV) can be calculated. Further
correction for intrathoracic blood volume yields a value for
EVLW. This can be achieved through injection of a single
thermal indicator, obviating the need to use indocyanine
green dye [46,47].
Since the extravascular water content of myocardium and
non-pulmonary blood vessels is small relative to the
extravascular water content of the lung, ETV and EVLW
are usually considered to be equivalent. Many studies
have shown that ETV usually (but not always) closely
approximates EVLW [43,44]. The thermal capacitance of
the non-aqueous structures may, however, be significant,
leading to overestimates of EVLW of 10–15% [48]. Effros
[42] and Allison et al. [44] have both pointed out that the
measurement of ETV is only equal to EVLW if the rela-
tive transit times of the thermal indicator through red cells
versus plasma, the relative specific heats of extravascular
tissue versus plasma, the density of blood, and the fraction
of extravascular mass represented by water are all taken
into account. Without such corrections, ETV should con-
sistently overestimate EVLW by as much as 24% in
normal lungs. Interestingly, as the lungs become more
edematous, a greater fraction of the extravascular mass
becomes water, and the error introduced by ignoring these
factors (which is the case with commercially available
devices) actually goes down.
While the theory underlying these measurements is well
understood [42], commercially available equipment may
have seriously biased the interpretation of performance in
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systems (COLD Z-03® and PiCCO®, Pulsion Medizin-
technik, Munich, Germany) currently available for clinical
use, many of the technical problems associated with the
earlier equipment have apparently been addressed
[44–46].
Overall, the correlation coefficient (r) for ETV and gravi-
metrically determined EVLW is usually at least 0.9 and
the slope of the regression relationship is usually between
0.9 and 1.10 [43–45]. Using animal data, sensitivity has
been estimated to be 88% and specificity 97%, with a
coefficient of variation for repeated measurements of
4–8% [44]. This performance record in animals may be
somewhat optimistic for the usual intensive care unit clini-
cal setting. Using the ‘COLD®’ system, Zeravik et al. [51]
reported a coefficient of variation of about 8%. Similarly, a
strong correlation (r=0.98) with close absolute agreement
between ETV and gravimetric measurements obtained
from the lungs of organ donors has been reported [48].
The advantages of measuring EVLW by the single or
double indicator dilution methods are several; the methods
are (superficially) simple to implement, safe, reproducible,
and repeatable. On the other hand, they are somewhat
invasive (it requires central venous as well as arterial
catheterization). In addition, the accumulation of extravas-
cular water in any portion of lung that is downstream from
a large vascular obstruction cannot be detected [44]. An
analogous problem exists for lung regions that are simply
poorly perfused, for instance as a result of using positive
end-expiratory pressure (PEEP) [42,44,52].
Conclusion
None of the methods for measuring EVLW, other than
chest radiography, have been widely incorporated into
clinical practice. One reason is undoubtedly that no one
has shown that a measurement of EVLW per se is needed
for sound clinical decision making during the treatment of
pulmonary edema. Similarly, no one has shown that incor-
porating such methods into routine clinical practice will
affect patient outcome. Although the potential value of
having a quantitative measure of pulmonary edema seems
obvious (such as a treatment endpoint surrogate for mor-
tality in clinical trials) and various studies have suggested
how such measurements might be used in clinical decision
making [48], a convincing outcome study demonstrating
benefit is still needed.
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